Invention Application
- Patent Title: Cyclin dependent kinase inhibitor
- Patent Title (中): 细胞周期蛋白依赖性激酶抑制剂
-
Application No.: US09816001Application Date: 2001-03-23
-
Publication No.: US20020065293A1Publication Date: 2002-05-30
- Inventor: Libor Havlicek , Miroslav Strnad , Marian Hajduch
- Applicant: Institute of Experimental Botany of the Academy of Sciences of the Czech Republic
- Applicant Address: null
- Assignee: Institute of Experimental Botany of the Academy of Sciences of the Czech Republic
- Current Assignee: Institute of Experimental Botany of the Academy of Sciences of the Czech Republic
- Current Assignee Address: null
- Main IPC: A61K031/52
- IPC: A61K031/52
Abstract:
The present invention is based on the method of treating a patient suffering from leukemia comprising administering a therapeutically effective amount of the compound 2-(null(3-hydroxypropyl)aminonull-6-benzylamino)-9-isopropylpurine or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US06703395B2 Cyclin dependent kinase inhibitor Public/Granted day:2004-03-09
Information query
